Today, November 26th marks Myelofibrosis Awareness Day, shedding light on this rare disease impacting blood cell production within the bone marrow. Myelofibrosis involves the accumulation of fibrous and scar tissue in the bone marrow, hindering the normal functioning of stem cells.
The “Asociación Civil Linfomas, Mielodisplasias y Mielofibrosis de Argentina” (ACLA) initiated this crucial campaign, and the Global MPN Scientific Foundation joined in to amplify its international impact, recognizing the significance of this endeavor.
Content guide
Understanding Myelofibrosis
Myelofibrosis is a rare disease affecting blood cell production in the bone marrow. The bone marrow fills with fibrous and scar tissue that prevents the normal function of the stem cells. This causes anemia, neutropenia, and thrombocytopenia, low levels of red blood cells, white blood cells, and platelets. These problems can cause symptoms such as tiredness, infections, bleeding, and bruising.
Typically diagnosed in individuals over 60 years old, Myelofibrosis does not exhibit significant gender-based discrepancies. While the exact prevalence remains unclear, it's estimated to affect between 0.5 and 1.5 individuals per 100,000 inhabitants. Diagnosis involves blood tests and a bone marrow biopsy, a procedure that examines tissue samples under a microscope.
Exploring More about Myelofibrosis
For comprehensive insights into Myelofibrosis, treatment alternatives, and symptom management, join GMPNSF to delve deeper into this rare condition.
Connect with MF Patients
Are you or someone you know impacted by Myelofibrosis? Join the Global MPN Scientific Foundation to share experiences, connect with others affected by the condition, and foster awareness.